CIPLAstockCipla Ltd
₹1,348.1
▼-1.80%
Open
₹1,378.35
High
₹1,381.3
Low
₹1,341.75
Volume
2.04M
Price chart
Daily close · downsampled 5-year history
2021-06-21 · ₹9602026-06-18 · ₹1,350
Instrument details
- MB Code
- MBEQU5289
- Type
- stock
- ISIN
- INE059A01026
- BSE
- 500087
- Industry
- Pharmaceuticals & Biotechnology
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 6541.2 Cr
- Net profit
- 550.11 Cr
- EPS
- 6.86
- YoY revenue
- -2.80%
Price returns
Historical performance
- 1 day
- -0.06%
- 1 month
- -4.24%
- 3 months
- +7.50%
- 1 year
- -9.90%
- 3 years
- +33.46%
- 5 years
- +40.59%
Technicals
Indicator consensus
Bullish
18
Neutral
2
Bearish
26
RSI 24.69(Bullish)
Company documents
Annual reports, concalls, presentations
Concall transcripts
96Investor presentations
102Corporate announcements
364Corporate timeline
Price chart events · 1 year
Dividend
2025-06-27
{"amount":13}
Dividend
2025-06-27
{"amount":3}
Dividend
2026-06-05
{"amount":13}
Earnings
2025-07-25
{"actualRevenue":69574700000,"estimateRevenue":72761000000,"revenueSurprise":-3186300000,"revenueSurprisePercent":-4.379131677684474,"actualEPS":16.06,"estimateEPS":14.876084,"surprise":1.183915999999998,"surprisePercent":7.958519190937603}
Earnings
2025-10-30
{"actualRevenue":75894400000,"estimateRevenue":76527000000,"revenueSurprise":-632600000,"revenueSurprisePercent":-0.8266363505690802,"actualEPS":16.72,"estimateEPS":16.56034,"surprise":0.1596599999999988,"surprisePercent":0.9641106402404709}
Earnings
2026-01-23
{"actualRevenue":70744800000,"estimateRevenue":76997000000,"revenueSurprise":-6252200000,"revenueSurprisePercent":-8.120056625582816,"actualEPS":8.363,"estimateEPS":15.780115,"surprise":-7.417115000000001,"surprisePercent":-47.00292108137361}
Earnings
2026-05-13
{"actualRevenue":65412000000,"estimateRevenue":69514000000,"revenueSurprise":-4102000000,"revenueSurprisePercent":-5.900969588859798,"actualEPS":6.86,"estimateEPS":9.9718832,"surprise":-3.1118832,"surprisePercent":-31.20657490252192}
News
2026-05-14
{"description":"Cipla rose over 7% after Q4FY26 results triggered at least six analyst upgrades; JPMorgan and Citi raised targets on better US pipeline visibility, while management guided FY27 US sales at $1 billion.","url":"https://www.cnbctv18.com/market/cipla-share-price-jumps-after-at-least-six-analyst-upgrades-on-q4-results-outlook-us-business-pipeline-ws-l-19905491.htm","sentiment":"Positive","domain":"CNBCTV18"}
News
2026-05-13
{"description":"Cipla shares rose after Q4 results showed US sales at $155 million and adjusted EBITDA margins near estimates; board approved a final dividend of ₹13 per share with record date June 5, 2026.","url":"https://www.cnbctv18.com/market/cipla-q4-results-impairment-cost-impact-us-sales-margins-share-price-move-19904718.htm","sentiment":"Positive","domain":"CNBCTV18"}
News
2026-05-13
{"description":"Cipla reported Q4 net profit fell 55% to Rs 555 crore as revenue declined and expenses rose; the board also announced a dividend, signaling weaker quarterly performance.","url":"https://www.moneycontrol.com/news/business/earnings/cipla-q4-results-net-profit-falls-55-on-year-to-rs-555-crore-revenue-marginally-down-13917745.html","sentiment":"Negative","domain":"Moneycontrol"}